You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Chronic Cough: 2021 Mid-Year Check-In on New Developments

  • Authors: Peter V. Dicpinigaitis, MD; Alan B. Goldsobel, MD; Jacky Smith, ChB, FRCP, PhD
  • CME / ABIM MOC Released: 7/1/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 7/1/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care physicians, allergists & clinical immunologists, and pulmonologists.

The goal of this activity is to increase clinicians’ knowledge regarding current and emerging therapies for chronic cough to improve patient outcomes.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data on emerging therapies for chronic cough
    • Advances in the management of patients with chronic cough


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Peter V. Dicpinigaitis, MD

    Professor of Medicine
    Albert Einstein College of Medicine
    Division of Critical Care
    Montefiore Medical Center
    Director, Montefiore Cough Center
    Bronx. New York

    Disclosures

    Disclosure: Peter V. Dicpinigaitis, MD, has the following relevant financial relationships:
    Advisor or consultant for: Bayer HealthCare Pharmaceuticals; Bayer AG; BELLUS Health Inc.; Merck & Co., Inc.; Shionogi & Co., Ltd.

  • Alan B. Goldsobel, MD

    Allergy and Asthma Associates of Northern California
    San Jose, California
    Clinical Professor of Medicine
    University of California, San Francisco
    Adjunct Associate Professor
    Stanford University Medicine Center
    Stanford, California

    Disclosures

    Disclosure: Alan B. Goldsobel, MD, has the following relevant financial relationships:
    Advisor or consultant for: BELLUS Health Inc.; Merck & Co., Inc.
    Speaker or a member of a speakers bureau for: Merck & Co., Inc.
    Grants for clinical research from: BELLUS Health Inc.; Merck & Co., Inc.

  • Jacky Smith, ChB, FRCP, PhD

    Professor of Respiratory Medicine
    Division of Infection, Immunity & Respiratory Medicine
    Lydia Becker Institute of Immunology and Inflammation
    University of Manchester
    Manchester, United Kingdom

    Disclosures

    Disclosure: Jacky Smith, ChB, FRCP, PhD, has the following relevant financial relationships:
    Advisor or consultant for: Algernon; Bayer AG; BELLUS Health Inc.; Merck & Co., Inc.; Nocion Therapeutics; Shionogi & Co., Ltd.
    Speaker or a member of a speakers bureau for: Merck & Co., Inc.
    Grants for clinical research from: Merck & Co., Inc.
    Other: Vitalograph Ltd.

Editor

  • Roderick Smith, MS

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Roderick Smith, MS, has disclosed no relevant financial relationships.

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Chronic Cough: 2021 Mid-Year Check-In on New Developments

Authors: Peter V. Dicpinigaitis, MD; Alan B. Goldsobel, MD; Jacky Smith, ChB, FRCP, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 7/1/2021

Valid for credit through: 7/1/2022

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Introduction

Dr Dicpinigaitis provides a program overview.
Peter V. Dicpinigaitis, MD

Overview of Chronic Cough

Dr Goldsobel provides an overview of chronic cough.
Alan B. Goldsobel, MD

Established Treatments and Emerging Treatment Targets

Dr Smith reviews the pathophysiology of cough and targets for therapy.
Jacky Smith, ChB, FRCP, PhD

Emerging Treatments: New Data From ATS 2021

Dr Dicpinigaitis discusses key data from ATS 2021
Peter V. Dicpinigaitis, MD

Clinical Context and Concluding Remarks

Dr Dicpinigaitis gives concluding remarks.
Peter V. Dicpinigaitis, MD
 
  • Print